Mainz Biomed (MYNZ) announced that Robert Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber (QUCY) and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Liscouski and the change of Company name will become effective at the Company’s extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on March 12, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYNZ:
- Mainz Biomed cut to Hold at Maxim on shift in capital structure
- Mainz Biomed downgraded to Hold from Buy at Maxim
- Mainz Biomed Secures Strategic Investment and Restructures Operations
- Mainz Biomed to focus on pancreatic cancer detection business in the U.S.
- Mainz Biomed completes ATM share sales, retains capacity